Weiss Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Weiss Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,428	Closed	-$1.9M	–	614
2021 Q2	$1.9M	Buy	+9,428	New	+$1.97M	0.05%	310
2018 Q4	–	Sell	-3,808	Closed	-$734K	–	491
2018 Q3	$734K	Hold	3,808	–	–	0.06%	110
2018 Q2	$647K	Hold	3,808	–	–	0.06%	108
2018 Q1	$621K	Hold	3,808	–	–	0.05%	108
2017 Q4	$571K	Buy	3,808 +2,145	+129%	+$318K	0.05%	111
2017 Q3	$253K	Buy	+1,663	New	+$250K	0.03%	86

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Weiss Asset Management's VRTX Position: Q3 2021 in Review

Weiss Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2021, closing a stake of 9,428 shares — an estimated $1.9M sold.

Weiss Asset Management first reported a position in VRTX in Q3 2017 and held it in 6 quarters. The position peaked at $1.9M in Q2 2021. 933 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

Weiss Asset Management reported no remaining Vertex Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Weiss Asset Management sold 9,428 Vertex Pharmaceuticals shares in Q3 2021, an estimated $1.9M.
Weiss Asset Management first reported a position in Vertex Pharmaceuticals in Q3 2017 and held it in 6 quarters.
Weiss Asset Management's Vertex Pharmaceuticals position peaked at $1.9M in Q2 2021.
933 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on Weiss Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.